Results 21 to 30 of about 46,971 (258)

Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis [PDF]

New England Journal of Medicine, 2009
Invasive pneumococcal disease declined among children and adults after the introduction of the pediatric heptavalent pneumococcal conjugate vaccine (PCV7) in 2000, but its effect on pneumococcal meningitis is unclear.We examined trends in pneumococcal meningitis from 1998 through 2005 using active, population-based surveillance data from eight sites in
Matthew R. Moore, Nancy M. Bennett, Arthur Reingold, Monica M. Farley, William Schaffner, Heather E. Hsu, Lee H. Harrison, Lee H. Harrison, Susan Petit, Kathleen A. Shutt, James H. Jorgensen, Bernard Beall, Catherine Lexau, Allen S. Craig, Cynthia G. Whitney, Ann Thomas   +15 more
openaire   +3 more sources

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

The Pediatric Infectious Disease Journal, 2020
Supplemental Digital Content is available in the text. Background: Pneumococcal disease remains a public health priority worldwide. This phase 2 study (V114-008; NCT02987972; EudraCT 2016-001117-25) compared safety and immunogenicity of 2 clinical lots ...
H. Platt, D. Greenberg, B. Tapiéro, R. Clifford, N. Klein, D. Hurley, T. Shekar, Jianing Li, Kim Hurtado, Shu-Chih Su, Katrina M. Nolan, C. Acosta, Richard D. McFetridge, K. Bickham, L. Musey   +14 more
semanticscholar   +1 more source

Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review.

PLoS ONE, 2019
BackgroundDespite the widespread implementation of the pneumococcal conjugate vaccine, Streptococcus pneumoniae remains the leading cause of severe pneumonia associated with mortality among children less than 5 years of age worldwide, with the highest ...
James Samwel Ngocho, Best Magoma, Gaudencia Alois Olomi, Michael Johnson Mahande, Sia Emmanueli Msuya, Marien Isaäk de Jonge, Blandina Theophil Mmbaga   +6 more
doaj   +1 more source

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices

MMWR. Morbidity and mortality weekly report, 2019
Two pneumococcal vaccines are currently licensed for use in adults in the United States: a 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Pfizer, Inc.]) and a 23-valent pneumococcal polysaccharide vaccine (PPSV23 [Pneumovax 23, Merck and Co.
Almea M Matanock, Grace M. Lee, R. Gierke, Miwako Kobayashi, A. Leidner, T. Pilishvili   +5 more
semanticscholar   +1 more source

Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies

Lancet Global Health, 2020
Summary Background The population impact of pneumococcal conjugate vaccines (PCVs) depends on direct and indirect protection. Following Malawi's introduction of the 13-valent PCV (PCV13) in 2011, we examined its impact on vaccine and non-vaccine serotype
N. Bar-Zeev, T. Swarthout, D. Everett, M. Alaerts, J. Msefula, C. Brown, Sithembile Bilima, J. Mallewa, Carina King, A. von Gottberg, J. Verani, C. Whitney, C. Mwansambo, S. Gordon, N. Cunliffe, N. French, R. Heyderman   +16 more
semanticscholar   +1 more source

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands

Emerging Infectious Diseases, 2015
Three years after a 7-valent pneumococcal conjugate vaccine was replaced by a 10-valent pneumococcal conjugate vaccine in the Netherlands, we observed a decrease in incidence of invasive pneumococcal disease caused by Streptococcus pneumoniae serotypes 1,
Mirjam J. Knol, Gertjan H.J. Wagenvoort, Elisabeth A.M. Sanders, Karin Elberse, Bart J. Vlaminckx, Hester E. de Melker, Arie van der Ende   +6 more
doaj   +1 more source

Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey

Human Vaccines & Immunotherapeutics, 2017
Invasive pneumococcal infections among children are a serious public health problem in many countries, including Turkey. Pneumococcal conjugate vaccine has been included in Turkey's National Immunization Programme since 2009.
Ayşe Büyükcam, Hüseyin Güdücüoğlu, Kamuran Karaman, Venhar Gürbüz, Emil Aliyev, Ateş Kara, Mehmet Ceyhan   +6 more
doaj   +1 more source

Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001–2016

Pediatrics, 2020
Using population-based national surveillance data, we compared rates of IPD among children
T. Adebanjo, Tracy Pondo, D. Yankey, H. Hill, R. Gierke, M. Apostol, M. Barnes, S. Petit, M. Farley, L. Harrison, C. Holtzman, Joan Baumbach, N. Bennett, S. McGuire, A. Thomas, W. Schaffner, B. Beall, C. Whitney, T. Pilishvili   +18 more
semanticscholar   +1 more source

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

New England Journal of Medicine, 2015
BACKGROUND Pneumococcal polysaccharide conjugate vaccines prevent pneumococcal disease in infants, but their efficacy against pneumococcal community-acquired pneumonia in adults 65 years of age or older is unknown. METHODS In a randomized, double-blind,
M. Bonten, S. Huijts, M. Bolkenbaas, Chris Webber, S. Patterson, S. Gault, C. H. van Werkhoven, A. V. van Deursen, E. Sanders, T. Verheij, Michael Patton, A. McDonough, A. Moradoghli-Haftvani, Helen M Smith, Tracey Mellelieu, M. Pride, Graham R. Crowther, B. Schmoele-Thoma, D. Scott, K. Jansen, R. Lobatto, B. Oosterman, Nils Visser, E. Caspers, Andre J. Smorenburg, E. Emini, W. Gruber, D. Grobbee   +27 more
semanticscholar   +1 more source

Adesão às novas vacinas conjugadas. Vacina anti-meningocócica e anti-pneumocócica.

Acta Médica Portuguesa, 2004
The new conjugate vaccines against group C meningococcal infection and pneumococcal infection were introduced in Portugal in 2001. In 2001/2002, the media published several alarming news on meningococcal disease and there was an increased demand of those
Laurinda De Queirós, Luis Castro, Maria Carmo Ferreira, Guilherme Gonçalves   +3 more
doaj   +1 more source